Machine learning predicts stem cell transplant response in severe scleroderma
Jennifer M. Franks(Dartmouth College), Michael L. Whitfield(Dartmouth–Hitchcock Medical Center), Maureen D. Mayes(The University of Texas Health Science Center), Keith M. Sullivan(Duke Medical Center), Lynette Keyes-Elstein(National Institute of Allergy and Infectious Diseases), Daniel E. Furst(University of California, Los Angeles), Richard A. Nash(Colorado Blood Cancer Institute), Leslie J. Crofford(Vanderbilt University Medical Center), Tammara Wood(Dartmouth College), Yue Wang(Florida State University), Peter A. McSweeney(Mesoblast (United States)), Viktor Martyanov(Dartmouth College), Ellen Goldmuntz(National Institute of Allergy and Infectious Diseases), Ashley Pinckney(National Institute of Allergy and Infectious Diseases)
Cited by 43
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
|Arthritis & Rheumatology|2015|2.8k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k